Compound 22 reduced the stemness of BC stem cells via blocking the interaction between LSD1 and the methylated histone H3, disintegrating the assembled co-repressor complex LSD1/RCOR1/CoREST, disturbing the occupation of LSD1 to the SOX2 promoter and finally reducing the SOX2 level. Here, SOX2 is linked to breast cancer.